Wegovy pill weight loss results: what the evidence shows
- What Wegovy pill results mean, and why appetite and the scale don't always move together
- What the OASIS 4 trial found, and how its two analyses differ
- How many trial participants reached 5% and 10% weight loss
- How long the Wegovy pill takes to work, and why early months differ from maintenance
- Which factors can influence your results
- When to review progress with your prescriber
What should you expect from oral semaglutide?
According to the UK Summary of Product Characteristics (SmPC), Wegovy tablets are for adults with a BMI of 30 or more, or 27 to 30 with at least one weight-related health condition, used as an adjunct to a reduced-calorie diet and increased physical activity.
According to the SmPC, semaglutide works by reducing your appetite, so you take in less energy from food and lose weight over time. That's why many people notice they feel full sooner before they see much change on the scale. Your weight also goes up and down a little from day to day with fluid and digestion, so a smaller appetite won't always show up straight away as a lower reading.
Good to know
Individual response varies. Some people lose more than the trial average and some lose less, even when taking the medicine exactly as directed.
What did the OASIS 4 trial find?
OASIS 4 is the main study behind the UK licence for the 25 mg Wegovy pill. It was published in the New England Journal of Medicine in 2025.
- Who took part: 307 adults without diabetes, living with obesity, or with overweight and at least one weight-related health condition. Average starting weight was around 105 kg.
- What they took: 205 people took oral semaglutide 25 mg once a day and 102 took a placebo, a tablet with no active medicine. Both groups also had diet and activity support.
- How long: 64 weeks
The main result
After 64 weeks, people taking the tablets lost an average of 13.6% of their body weight, compared with 2.2% in the placebo group. This figure counts everyone who joined the trial, including people who stopped the tablets early or started another weight-loss treatment. Researchers call this the treatment-policy analysis, and it's the closest to what happens in everyday life.
Why you may also see 16.6%
The trial also estimated what would have happened if everyone had kept taking the tablets for the full 64 weeks, with no other weight-loss treatment. On that assumption, average weight loss was 16.6% versus 2.8% with placebo. Because it imagines that nobody stopped, it's a best-case estimate rather than the result most people should expect.
| Treatment-policy analysis | On-treatment analysis | |
|---|---|---|
| Population | Adults with BMI ≥30, or ≥27 with a weight-related condition, without diabetes (n=307) | Same randomised population, data used until first discontinuation |
| Dose | Oral semaglutide 25 mg once daily, after monthly escalation | Oral semaglutide 25 mg once daily, after monthly escalation |
| Duration | 64 weeks | 64 weeks |
| Comparator | Placebo, both groups with lifestyle intervention | Placebo, both groups with lifestyle intervention |
| Analysis method | All data, regardless of stopping treatment or starting other weight-loss therapy | Assumes everyone stayed on treatment with no additional anti-obesity therapy |
| Mean body-weight change at week 64 | -13.6% vs -2.2% | -16.6% vs -2.8% |
Source: Wegovy 25 mg tablets SmPC (section 5.1) and Wharton et al., NEJM 2025.
How many people reached 5% or 10% weight loss?
By week 64, around 3 in 4 people taking the tablets had lost at least 5% of their body weight, and around 6 in 10 had lost at least 10%. These figures are group results, not a promise for any individual.
| Weight loss at week 64 | Oral semaglutide 25 mg (205 people) | Placebo (102 people) |
|---|---|---|
| At least 5% | 76.3% | 30.5% |
| At least 10% | 59.8% | 14.1% |
How long does the Wegovy pill take to work?
Wegovy tablets start at a low dose and step up gradually, with at least 1 month at each level:
- Month 1: 1.5 mg once daily
- Month 2: 4 mg once daily
- Month 3: 9 mg once daily
- Month 4 onwards: 25 mg once daily, the maintenance dose
The first 3 months give your body time to adjust and help keep side effects like nausea down. You're on a lower dose during this time, so don't expect the same results as on 25 mg. If a step up doesn't suit you, your prescriber can keep you on your current dose for longer.
The main trial measured results after 64 weeks, about 15 months. It doesn't give a week-by-week guide, so early change is best seen as the start of a longer process rather than a sign of where you'll end up.
What can influence your results?
Many factors shape your response, and most aren't about willpower.
- How you take the tablet: the SmPC directs taking it on an empty stomach after at least 8 hours of fasting, with up to 120 mL of water, then waiting at least 30 minutes before eating, drinking or taking other oral medicines. The SmPC notes absorption of oral semaglutide can vary, which is why consistent timing matters.
- Adherence: taking the tablet every day as directed
- Dose tolerance: some people need longer at a lower dose before stepping up
- Time on treatment: the trial outcomes were measured after 64 weeks
- Starting weight: results are reported as a percentage, so the same percentage means a different number of kilograms for different people
- Diet, physical activity and sleep
- Other medicines and medical conditions, which your prescriber will review
Tip
If your progress feels slower than expected, raise it with your prescriber. There may be practical reasons worth reviewing, such as tablet timing or dose tolerance.
When should you review progress with your prescriber?
The Wegovy tablets SmPC doesn't set a fixed review point, so timing is agreed with your UK-registered prescriber. It's worth booking a review if side effects aren't settling, you're struggling with the escalation schedule or your progress has stalled.
Important!
Seek urgent medical help for severe, persistent abdominal pain, which the SmPC lists as a possible sign of pancreatitis.
Continuing or stopping treatment is a clinical decision to make with your prescriber. We don't yet know what happens to weight after stopping the tablets. The closest evidence comes from the Wegovy injection: in a study that followed people for a year after their injections ended, weight tended to creep back up, but on average they were still 5.6% lighter than before treatment. The tablets may not follow the same pattern.
Final thoughts
In the main trial, people taking the Wegovy pill lost an average of 13.6% of their body weight over around 15 months, and most lost at least 5%. Your own Wegovy pill weight loss results will depend on how you take the tablet, how well you get on with each dose, how long you stay on treatment and the changes you make to eating and activity. DoktorABC connects UK patients with UK-registered prescribers who can assess suitability and review your progress over time.
FAQ
What are typical Wegovy pill results?
In OASIS 4, people taking oral semaglutide 25 mg lost an average of 13.6% of their body weight at 64 weeks in the treatment-policy analysis, compared with 2.2% on placebo. Individual results vary.
How long does the Wegovy pill take to work?
You may notice appetite changes early, but you reach the maintenance dose from month 4, and the trial's main result was measured at week 64.
Why do you see both 13.6% and 16.6% quoted for Wegovy pill results?
They come from different analyses. 13.6% includes everyone randomised; 16.6% assumes everyone stayed on treatment without other weight-loss therapy.
Is the Wegovy pill more effective than the injection?
There's no head-to-head trial comparing them, so a direct comparison can't be made.
What happens if I miss a dose?
The patient information leaflet advises skipping the missed dose and taking your normal dose the next day.
The DoktorABC medical advisory board
Dr. Roland Ruiken
Medical advisor, Norway
Dr. Viktor Simunovic
Medical advisor, Croatia